B7H3-SADA (Y-mAbs Therapeutics)

N/A

Report date: 2024/03/21 15:02:05

Base Information

Drug NameB7H3-SADA (Y-mAbs Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyRadiation-emitting products > Radioactive therapeutic agent
Mechanisms of ActionApoptosis stimulantsIonising radiation emitters
TargetsUpdating
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMassachusetts Institute Of TechnologyMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesY-Mabs Therapeutics Inc
Inactive CompaniesMemorial Sloan Kettering Cancer CenterMassachusetts Institute Of Technology
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A